INDV - Indivior Pharmaceuticals Inc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$48.00
DETAILS
HIGH:
$50.00
LOW:
$46.00
MEDIAN:
$48.00
CONSENSUS:
$48.00
UPSIDE:
18.52%
About Indivior Pharmaceuticals Inc (https://www.indivior.com)
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Joseph J. Ciaffoni | Chief Executive Officer & Director | 1971 | $3,551,792 USD |
| Patrick A. Barry | Chief Commercial Officer | 1968 | $2,071,194 USD |
| Christian Heidbreder | Chief Scientific Officer | 1963 | $1,492,872 USD |
| Ryan Preblick | Chief Financial Officer | 1976 | $1,289,326 USD |
| Jeffrey W. Burris | Chief Legal Officer | 1972 | $1,183,354 USD |
| Alice G. Givens | Company Secretary | 1974 | – |
| Angela Colon-Mahoney | Chief Human Resources Officer | 1976 | – |
| Jason Thompson | Vice President of Investor Relations | – | – |
| Kevin L. Espinoza | Chief Integrity & Compliance Officer | – | – |
| Vanessa Procter | Executive Vice President of Corporate Affairs | – | – |